Canada markets closed

Valeo Pharma Inc. (VPHIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.10500.0000 (0.00%)
At close: 11:23AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.1050
Open0.1050
BidN/A x N/A
AskN/A x N/A
Day's Range0.1050 - 0.1050
52 Week Range0.1000 - 0.4497
Volume17,000
Avg. Volume954
Market Cap10.359M
Beta (5Y Monthly)2.53
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • CNW Group

    VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE

    Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that Steve Saviuk, Valeo's Chief Executive Officer, will present and participate in one-on-one meetings at the 2024 Bloom Burton & Co. Healthcare Investor Conference, which is scheduled to take place at the Metro Toronto Convention Centre in Toronto from April 16-17, 2024.

  • CNW Group

    VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS

    Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that Mr. Al Moghaddam has joined the Company's Board of Directors.

  • CNW Group

    VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTS

    Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today reported its financial results for the first quarter ended January 31, 2024.